Bank of New York Mellon’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-253
| Closed | -$11.1K | – | 4396 |
|
|
2023
Q4 | $11.1K | Hold |
253
| – | – | ﹤0.01% | 4265 |
|
|
2023
Q3 | $11.5K | Hold |
253
| – | – | ﹤0.01% | 4286 |
|
|
2023
Q2 | $16.9K | Hold |
253
| – | – | ﹤0.01% | 4306 |
|
|
2023
Q1 | $10.9K | Hold |
253
| – | – | ﹤0.01% | 4351 |
|
|
2022
Q4 | $7.88K | Hold |
253
| – | – | ﹤0.01% | 4433 |
|
|
2022
Q3 | $15K | Hold |
253
| – | – | ﹤0.01% | 4481 |
|
|
2022
Q2 | $20K | Sell |
253
-23
| -8% | -$2.21K | ﹤0.01% | 4496 |
|
|
2022
Q1 | $29K | Hold |
276
| – | – | ﹤0.01% | 4596 |
|
|
2021
Q4 | $25K | Hold |
276
| – | – | ﹤0.01% | 4577 |
|
|
2021
Q3 | $56K | Buy |
276
+23
| +9% | +$4.64K | ﹤0.01% | 4424 |
|
|
2021
Q2 | $54K | Hold |
253
| – | – | ﹤0.01% | 4320 |
|
|
2021
Q1 | $57K | Sell |
253
-27
| -10% | -$6.1K | ﹤0.01% | 4241 |
|
|
2020
Q4 | $50K | Hold |
280
| – | – | ﹤0.01% | 4149 |
|
|
2020
Q3 | $60K | Buy |
+280
| New | +$69.9K | ﹤0.01% | 4003 |
|
|
2018
Q2 | – | Sell |
-2
| Closed | -$4K | – | 4455 |
|
|
2018
Q1 | $4K | Sell |
2
-1
| -33% | -$2.09K | ﹤0.01% | 4308 |
|
|
2017
Q4 | $5K | Hold |
3
| – | – | ﹤0.01% | 4348 |
|
|
2017
Q3 | $5K | Sell |
3
-3
| -50% | -$5.26K | ﹤0.01% | 4259 |
|
|
2017
Q2 | $13K | Buy |
6
+3
| +100% | +$7.42K | ﹤0.01% | 4260 |
|
|
2017
Q1 | $9K | Buy |
+3
| New | +$7.67K | ﹤0.01% | 4260 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$8K | – | 4429 |
|
|
2016
Q2 | $8K | Hold |
1
| – | – | ﹤0.01% | 4303 |
|
|
2016
Q1 | $9K | Hold |
1
| – | – | ﹤0.01% | 4201 |
|
|
2015
Q4 | $5K | Hold |
1
| – | – | ﹤0.01% | 4320 |
|
|
2015
Q3 | $11K | Hold |
1
| – | – | ﹤0.01% | 4350 |
|
|
2015
Q2 | $14K | Sell |
1
-1
| -50% | -$12.4K | ﹤0.01% | 4247 |
|
|
2015
Q1 | $30K | Hold |
2
| – | – | ﹤0.01% | 4172 |
|
|
2014
Q4 | $31K | Buy |
2
+1
| +100% | +$14.9K | ﹤0.01% | 4182 |
|
|
2014
Q3 | $22K | Hold |
1
| – | – | ﹤0.01% | 4201 |
|
|
2014
Q2 | $21K | Hold |
1
| – | – | ﹤0.01% | 4132 |
|
|
2014
Q1 | $27K | Buy |
+1
| New | +$21.2K | ﹤0.01% | 4133 |
|
|
2013
Q3 | – | Sell |
-3
| Closed | -$30K | – | 4298 |
|
|
2013
Q2 | $30K | Buy |
+3
| New | +$35.8K | ﹤0.01% | 4083 |
|
Other funds holding AIM
BCM
SWM
Bank of New York Mellon's AIM Position: Q1 2024 in Review
Bank of New York Mellon sold out of AIM ImmunoTech (AIM) in Q1 2024, closing a stake of 253 shares — an estimated $11.1K sold.
Bank of New York Mellon first reported a position in AIM in Q2 2013 and held it in 30 quarters. The position peaked at $60K in Q3 2020. 28 funds tracked by Wall St. Rank hold AIM as of Q1 2024.
- Bank of New York Mellon reported no remaining AIM ImmunoTech position as of Q1 2024 after selling out during the quarter.
- Bank of New York Mellon sold 253 AIM ImmunoTech shares in Q1 2024, an estimated $11.1K.
- Bank of New York Mellon first reported a position in AIM ImmunoTech in Q2 2013 and held it in 30 quarters.
- Bank of New York Mellon's AIM ImmunoTech position peaked at $60K in Q3 2020.
- 28 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2024.
Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.